Skip to main content
OpenTrials
Completed

NCT Number: NCT05172102

Quality of Life and Lung Function on Post Covid-19 Patient

Gaining a greater understanding of how the breathing exercise combined with aerobic and strengthening exercises will affects lung function and quality of life in post covid-19 persons

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

20 year–30 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

College of medical rehabilitation

Buraidah, Al-Qassim Region, 2100, Saudi Arabia

About this study

this will improve exercise prescription guidelines relevant to this post covid-19. Therefore, the purpose of this work was determining the effect of breathing exercise combined with aerobic and strengthening exercises in improve chest expansion, lung function and quality of life in post covid-19 persons.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female. Age from 20 to 30 years old. - Body mass index (BMI) 19 to 24 kg/m2.- Non-smoker- Recovered from COVID-19 over the past 12 months. - They are experiencing mild to moderate symptoms without any complications. -
  • Able to use online communication programs.

Exclusion criteria

  • - Anyone who does regular physical exercise.
  • history of acute illness, asthma, pulmonary fibrosis, hypertension, diabetes disease.
  • hypoxemia in rest.

Treatment and study plan

breathing exercise, Aerobic exercises

Other

6 min of quiet breathing (3 sets of 2 min each), 6 min of diaphragmatic breathing (3 sets of 2 min each), 6 min of diaphragmatic breathing plus pursed-lips breathing (3 sets of 2 min each).

Other names: resistance exercises

Primary outcomes

  1. Health-related quality of life, Medical Outcomes Study short-form (SF-36)

    Time frame: at baseline

    assessed using the Short Form-36 (SF-36). The SF-36 scale had 8 dimensions, and each dimension was converted into a percentage score.

  2. Health-related quality of life, Medical Outcomes Study short-form (SF-36)

    Time frame: after 6 weeks

    assessed using the Short Form-36 (SF-36). The SF-36 scale had 8 dimensions, and each dimension was converted into a percentage score.

  3. Respiratory function measurement

    Time frame: at baseline

    assessed by a spirometer. The following parameters related to respiratory function will be measured: (1) forced expiratory volume in 1 second (FEV1); (2) forced vital capacity (FVC).

  4. Respiratory function measurement

    Time frame: after 6 weeks

    assessed by a spirometer. The following parameters related to respiratory function will be measured: (1) forced expiratory volume in 1 second (FEV1); (2) forced vital capacity (FVC).

Secondary outcomes

  1. Chest expansion measurement

    Time frame: at baseline

    measured with a tape measure at 2 different levels of the rib cage. Measurements will be taken at the maximal inspiration and expiration

  2. Chest expansion measurement

    Time frame: after 6 weeks

    measured with a tape measure at 2 different levels of the rib cage. Measurements will be taken at the maximal inspiration and expiration

  3. Exercise endurance measurement

    Time frame: at baseline

    measured by the 6-min walk test (6MWT), is the distance one walks within 6 min

  4. Exercise endurance measurement

    Time frame: after 6 weeks

    measured by the 6-min walk test (6MWT), is the distance one walks within 6 min

Sponsors and collaborators

Lead sponsor

Qassim University

Other

Registry information

Official study title

Effect of Breathing Exercise on Chest Expansion, Quality of Life and Lung Function on Post Covid-19 Patient: A Randomized Controlled Trial

Acronym: Covid-19

Important dates

Study start
2021
Primary completion
2023
Study completion
2023
First posted
Dec 29, 2021
Registry last updated
Apr 4, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.